UCB adopts Veeva Safety Suite to unify global pharmacovigilance operations UCB is standardising its global pharmacovigilance operations on Veeva Safety Suite as part of a wider effort to streamline safety processes and increase automation across its organ... See more
Cartesian licenses WestGene platform to advance in vivo CAR-T for autoimmune diseases Cartesian Therapeutics has signed a strategic licensing agreement with WestGene Biopharma to accelerate development of in vivo CAR-T therapies for autoimmune diseases, w... See more
Gaelic Laboratories completes first phase of Athlone integration Gaelic Laboratories has completed the first phase of the integration of Athlone Laboratories following its acquisition of the Irish beta-lactam antibiotic manufacturer in December 2025. The ... See more
NICE backs AQUIPTA for acute migraine treatment in England and Wales The National Institute for Health and Care Excellence (NICE) has recommended AQUIPTA (atogepant) as an NHS treatment option for adults with acute migraine in England and Wales who have n... See more
SMC approves TALVEY for relapsed multiple myeloma in Scotland The Scottish Medicines Consortium (SMC) has accepted TALVEY (talquetamab) for use within NHS Scotland as a treatment for adults with relapsed and refractory multiple myeloma who have received a... See more
